Frequency and safety of switching antithrombin therapy at a regional PCI center

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Thrombosis and Thrombolysis

• Publication date

  2010-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11239-009-0377-4PMID 19593664
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bivalirudin during primary PCI in acute myocardial infarction.

  2008cited by this paper
• Patterns of transfer for patients with non-ST-segment elevation acute coronary syndrome from community to tertiary care hospitals.

  2008cited by this paper
• Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis.

  2008cited by this paper
• Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.

  2008cited by this paper
• Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology.

  2007cited by this paper
• Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial.

  2007cited by this paper
• ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie

  2007cited by this paper
• [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes].

  2007cited by this paper
• Use of heparins in Non-ST-elevation acute coronary syndromes.

  2007cited by this paper
• Enoxaparin dosing and associated risk of in-hospital bleeding and death in patients with non ST-segment elevation acute coronary syndromes.

  2007cited by this paper
• Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes.

  2007cited by this paper
• Vascular closure devices: the second decade.

  2007cited by this paper
• Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial.

  2007cited by this paper
• Impact of anaemia, bleeding, and transfusions in acute coronary syndromes: a shift in the paradigm.

  2007cited by this paper
• Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006.

  2007cited by this paper
• Comparison of fondaparinux and enoxaparin in acute coronary syndromes.

  2006cited by this paper
• A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes.

  2006cited by this paper
• Switching from Enoxaparin to Bivalirudin in Patients with Acute Coronary Syndromes without ST-segment Elevation who Undergo Percutaneous Coronary Intervention. Results from SWITCH--a multicenter clinical trial.

  2006cited by this paper
• Optimal Timing of Intervention in Non–ST-Segment Elevation Acute Coronary Syndromes: Insights From the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry

  2005cited by this paper
• Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes.

  2005cited by this paper
• Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.

  2004cited by this paper
• Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

  2004cited by this paper
• Use of the invasive management strategy for patients with non-Q-wave myocardial infarction: an observational database report from the Worcester Heart Attack Study.

  2002cited by this paper

• Current awareness: Pharmacoepidemiology and drug safety

  2010cites this paper